Erythromycin Ethylsuccinate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 75834-294
  • Package NDC 75834-294-01
  • Application number ANDA216212
  • SPL ID 7f06e8f4-15fb-4e18-b57e-457e7e20d331
  • SPL set ID 46f74c4f-10fc-44cf-aec4-d113f49149bc
  • UNII 1014KSJ86F
  • RxCUI 686400
  • RxCUI 686418

What the source publishes

Labeler
Nivagen Pharmaceuticals, Inc.
Active ingredients
Erythromycin Ethylsuccinate
Form
SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:75834-294_7f06e8f4-15fb-4e18-b57e-457e7e20d331
{
  "name": "Erythromycin Ethylsuccinate",
  "splId": "7f06e8f4-15fb-4e18-b57e-457e7e20d331",
  "labels": [
    {
      "setId": "46f74c4f-10fc-44cf-aec4-d113f49149bc",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46f74c4f-10fc-44cf-aec4-d113f49149bc",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=46f74c4f-10fc-44cf-aec4-d113f49149bc"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Nivagen Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "100 mL in 1 BOTTLE (75834-294-01)",
      "package_ndc": "75834-294-01",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230201"
    }
  ],
  "productId": "75834-294_7f06e8f4-15fb-4e18-b57e-457e7e20d331",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "75834-294",
  "deaSchedule": null,
  "genericName": "Erythromycin Ethylsuccinate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ERYTHROMYCIN ETHYLSUCCINATE",
      "strength": "400 mg/5mL"
    }
  ],
  "applicationNumber": "ANDA216212",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230201",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0375834295015",
      "0375834294018"
    ],
    "unii": [
      "1014KSJ86F"
    ],
    "rxcui": [
      "686400",
      "686418"
    ],
    "spl_set_id": [
      "46f74c4f-10fc-44cf-aec4-d113f49149bc"
    ],
    "manufacturer_name": [
      "Nivagen Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:75834-294_7f06e8f4-15fb-4e18-b57e-457e7e20d331"